Royal Bank of Canada
CLPT icon

Royal Bank of Canada’s ClearPoint Neuro CLPT Stock Holding History

Royal Bank of Canada’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4K Sell
505
-1,868
-79% -$23.6K ﹤0.01% 6478
2025
Q4 		$32K Sell
2,373
-14,850
-86% -$275K ﹤0.01% 5790
2025
Q3 		$376K Buy
17,223
+9,506
+123% +$112K ﹤0.01% 4687
2025
Q2 		$92K Buy
7,717
+6,420
+495% +$80.8K ﹤0.01% 5651
2025
Q1 		$15K Sell
1,297
-313
-19% -$4.87K ﹤0.01% 6009
2024
Q4 		$25K Buy
1,610
+1,050
+188% +$13.6K ﹤0.01% 6016
2024
Q3 		$6K Buy
560
+231
+70% +$2.21K ﹤0.01% 6451
2024
Q2 		$2K Sell
329
-1,699
-84% -$9.83K ﹤0.01% 6713
2024
Q1 		$13K Sell
2,028
-4,903
-71% -$34.3K ﹤0.01% 6091
2023
Q4 		$47K Buy
6,931
+3,290
+90% +$18.6K ﹤0.01% 6018
2023
Q3 		$19K Sell
3,641
-1,820
-33% -$10.8K ﹤0.01% 6193
2023
Q2 		$40K Buy
5,461
+5,287
+3,039% +$45K ﹤0.01% 5876
2023
Q1 		$1K Buy
+174
New +$1.52K ﹤0.01% 6866
2022
Q4 		– Sell
-404
Closed -$4K – 7273
2022
Q3 		$4K Buy
+404
New +$5.32K ﹤0.01% 6799
2022
Q2 		– Sell
-1,390
Closed -$14K – 7401
2022
Q1 		$14K Sell
1,390
-13,619
-91% -$124K ﹤0.01% 6790
2021
Q4 		$168K Buy
15,009
+515
+4% +$7.71K ﹤0.01% 5502
2021
Q3 		$258K Buy
14,494
+1,704
+13% +$32K ﹤0.01% 4934
2021
Q2 		$245K Buy
12,790
+290
+2% +$5.6K ﹤0.01% 4897
2021
Q1 		$264K Sell
12,500
-43,276
-78% -$926K ﹤0.01% 4717
2020
Q4 		$886K Buy
55,776
+55,276
+11,055% +$496K ﹤0.01% 3590
2020
Q3 		$3K Hold
500
– – ﹤0.01% 6222
2020
Q2 		$2K Buy
+500
New +$1.86K ﹤0.01% 6271

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Royal Bank of Canada's CLPT Position: Q1 2026 in Review

Royal Bank of Canada reduced its ClearPoint Neuro (CLPT) stake by 79% in Q1 2026, selling an estimated $23.6K and leaving 505 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #6478.

Royal Bank of Canada first reported a position in CLPT in Q2 2020 and has held it in 22 quarters since. The position peaked at $886K in Q4 2020. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

  • Royal Bank of Canada held 505 shares of ClearPoint Neuro worth $4K as of Q1 2026.
  • Royal Bank of Canada sold 1,868 ClearPoint Neuro shares in Q1 2026, an estimated $23.6K.
  • ClearPoint Neuro made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6478 holding.
  • Royal Bank of Canada first reported a position in ClearPoint Neuro in Q2 2020 and has held it in 22 quarters since.
  • Royal Bank of Canada's ClearPoint Neuro position peaked at $886K in Q4 2020.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.